Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Escalating Doses of GSK1325756 Solution for Infusion, and Absolute Bioavailability Relative of an Oral Dose, in Healthy Adult Subjects
Clinical trial NCT02169583 · COMPLETED
Trial details
- NCT number
- NCT02169583
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-12
- Primary completion
- 2014-08-28
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.